Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics

Conclusions: Our findings suggest that LIMCH1 may serve as a promising biomarker to predict LUAD prognosis.

Source: Journal of Cancer - January 15, 2021 Category: Cancer & Oncology Authors: He Cao, Jing Zhao, Zhen Chen, Wenjia Sun, Kexin Ruan, Jianya Zhou, Jianying Zhou Tags: Research Paper Source Type: research